HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.

AbstractOBJECTIVE:
Prophylactic bilateral salpingo-oophorectomy is advised for women with BRCA mutations, but there are adverse consequences of premature menopause. The majority of BRCA-associated ovarian cancers appear to arise in the fallopian tube; therefore, salpingectomy may be an alternative to bilateral salpingo-oophorectomy. We compared the costs and benefits of salpingectomy with bilateral salpingo-oophorectomy among BRCA mutation carriers.
METHODS:
We developed a Markov Monte Carlo simulation model to compare three strategies for risk reduction in women with BRCA mutations: 1) bilateral salpingo-oophorectomy; 2) bilateral salpingectomy; and 3) bilateral salpingectomy with delayed oophorectomy. Net health benefits were measured in years-of-life expectancy and quality-adjusted life-year expectancy, and the primary outcome was the incremental cost-effectiveness ratio. The model estimated the number of future breast and ovarian cancers and cardiovascular deaths attributed to premature menopause with each strategy.
RESULTS:
Bilateral salpingo-oophorectomy was associated with the lowest cost and highest life expectancy compared with the other two strategies. When quality-of-life measures were included, salpingectomy followed by delayed oophorectomy yielded the highest quality-adjusted life expectancy with incremental cost-effectiveness ratios of $37,805 and $89,680 per quality-adjusted life-year for BRCA1 and BRCA2, respectively, relative to salpingectomy alone. Bilateral salpingo-oophorectomy yielded the lowest number of future breast and ovarian cancers compared with the other two strategies.
CONCLUSION:
Bilateral salpingo-oophorectomy offers the greatest risk reduction for breast and ovarian cancer among BRCA mutation carriers. However, when considering quality-adjusted life expectancy, bilateral salpingectomy with delayed oophorectomy is a cost-effective strategy and may be an acceptable alternative for those unwilling to undergo bilateral salpingo-oophorectomy.
AuthorsJanice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 121 Issue 1 Pg. 14-24 (Jan 2013) ISSN: 1873-233X [Electronic] United States
PMID23232752 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Breast Neoplasms (economics, genetics, prevention & control)
  • Computer Simulation
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Humans
  • Mammaplasty (economics)
  • Markov Chains
  • Mastectomy (methods)
  • Middle Aged
  • Models, Biological
  • Mutation
  • Ovarian Neoplasms (economics, genetics, prevention & control)
  • Ovariectomy (methods)
  • Quality of Life
  • Quality-Adjusted Life Years
  • Risk Reduction Behavior
  • Salpingectomy (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: